Does ALEMTUZUMAB Cause Pulmonary embolism? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Pulmonary embolism have been filed in association with ALEMTUZUMAB (Campath). This represents 0.6% of all adverse event reports for ALEMTUZUMAB.
84
Reports of Pulmonary embolism with ALEMTUZUMAB
0.6%
of all ALEMTUZUMAB reports
19
Deaths
56
Hospitalizations
How Dangerous Is Pulmonary embolism From ALEMTUZUMAB?
Of the 84 reports, 19 (22.6%) resulted in death, 56 (66.7%) required hospitalization, and 23 (27.4%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ALEMTUZUMAB Alternatives Have Lower Pulmonary embolism Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET